Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome

Karina Forde, Nicoletta Resta, Carlotta Ranieri, David Rea, Olga Kubassova, Mark Hinton, Katrina A Andrews, Robert K Semple, Alan D Irvine, Veronika Dvorakova

Research output: Contribution to journalArticlepeer-review

Cite this